Barrington将阿尼卡医疗(Anika Therapeutics)的评级从“与大盘持平”上调至“跑赢大盘”,并给出目标价24美元。该行认为,该公司目前的风险回报水平“非常有利于投资”。#医疗# $阿尼哥医疗(ANIK)$查看全文
usbiostock2018-06-20 09:17
$阿尼哥医疗(ANIK)$ CINGAL® 16-02治疗膝盖骨关节炎临床3期试验未能满足主要终点。虽然在治疗后各个时间点,CINGAL® 16-02均能降低疼痛,但在主要终点(第26周)上却没有统计学意义。查看全文
usbiostock2018-06-20 09:17
$阿尼哥医疗(ANIK)$ CINGAL® 16-02治疗膝盖骨关节炎临床3期试验未能满足主要终点。虽然在治疗后各个时间点,CINGAL® 16-02均能降低疼痛,但在主要终点(第26周)上却没有统计学意义。查看全文
BlackPuma2014-10-30 07:44
10月中旬,福布斯依据最近12个月和过去五年的股本回报率、销售额增长和盈利增长,给出了销售额在10亿美元以下的美国小型上市公司TOP100榜单。相对于市值数十亿美元的大公司,小市值股对更多的投资者则代表着更为巨大的机会和增长潜力。
今年是福布斯第36届评选该榜单,入选TOP100企业遍及宇航...查看全文
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-14 AccNo: 0000846087-12-000004 Size: 19 KB 网页链接
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-14 AccNo: 0000902219-12-000049 Size: 19 KB 网页链接
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-13 AccNo: 0001095449-12-000006 Size: 9 KB 网页链接
SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-14 AccNo: 0000354204-12-001103 Size: 51 KB 网页链接
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-03 AccNo: 0001144204-12-005716 Size: 80 KB 网页链接
CT ORDER - Confidential treatment order Filed: 2012-01-30 AccNo: 9999999997-12-000505 Size: 14 KB 网页链接